Products & safety
Phthalates: plasticizers, food pathways, cosmetics and cumulative exposure
On this page
Phthalates are a family of chemicals used as plasticizers and in other applications. Different members have different uses, metabolism and toxicity evidence. A claim about one compound, one toy standard or one urine metabolite cannot automatically describe every phthalate exposure.[1]
The chemical family is not one interchangeable ingredient
Phthalates can make plastics flexible, but uses differ by compound. DEHP is associated with plasticizing PVC; DEP has been used in personal-care products. Exposure can come from diet and other everyday pathways. EPA's biomonitoring explanation emphasizes measuring breakdown products rather than assuming the original chemical persists unchanged. A flexible object does not identify which plasticizer it contains, and a phthalate-free claim does not reveal the toxicity or migration of the alternative.[1]
Separate food, fragrance and toys
FDA's food-contact page describes nine currently allowed phthalates: eight plasticizers and one monomer. They are not authorized to be added directly to food. Food contamination can involve contact materials rather than an ingredient intentionally placed in a recipe. FDA revoked authorizations for 23 phthalates in 2022 because those uses had been abandoned. An abandonment-based removal, a current authorization and a completed modern safety reassessment are separate regulatory facts.[2]
Fragrance labels have limits
DEP has been used as a fragrance solvent. Fragrance labels may omit individual constituents. Its posted position reports no safety concerns with DEP as currently used in cosmetics; that does not cover every phthalate or ingestion.[3]
Product percentage is not a personal dose
CPSC limits eight specified phthalates in covered children's toys and child-care articles to no more than 0.1 percent, equivalent to 1,000 parts per million. The categories include toys intended for children 12 or younger and specified care articles for age three or younger. This concentration restriction is a product requirement, not a urine concentration threshold or allowable daily intake. A testing exemption for certain materials does not remove the underlying compliance obligation.[4]
Evidence & uncertainty
This page distinguishes official assessments from observational research. A 2019 European assessment, a 2026 FDA grouping evaluation and US toy restrictions ask different questions. Their source count does not mean all possible compounds, outcomes and routes have been comprehensively assessed.[6]
Selected-source overview · Independent review pendingPublished questions
Are phthalates meant to be added to food?
Selected-source overview · Independent review pending. Read the evidence context.
FDA does not authorize direct addition to food. Its listed uses concern food-contact applications, where migration and actual exposure require separate assessment.[2]
Evidence behind this answer
- Phthalates in Food Packaging and Food Contact Applications
agency guidance or assessment · Date not stated
Original official page and selected relevant passages inspected · Authorizations, direct addition, 2022 abandonment and continued evaluation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are all phthalates assessed as equally toxic?
Selected-source overview · Independent review pending. Read the evidence context.
No. Grouping uses shared effects and relative potency; some compounds retain separate assessment. The family name does not supply an identical dose-response relationship.[5]
Evidence behind this answer
- Updated risk assessment of DBP, BBP, DEHP, DINP and DIDP
agency scientific opinion · 2019
Original official page and selected relevant passages inspected · Summary: temporary group TDI, relative potency, separate DIDP and uncertainty
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can an ingredient label identify every fragrance constituent?
Selected-source overview · Independent review pending. Read the evidence context.
Not necessarily. FDA permits a fragrance declaration without listing its individual constituents, so the label can leave composition uncertain.[3]
Evidence behind this answer
- Phthalates in Cosmetics
agency guidance or assessment · Date not stated
Original official page and selected relevant passages inspected · DEP use, fragrance constituent labeling and FDA position
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can a toy percentage be used as a urine limit?
Selected-source overview · Independent review pending. Read the evidence context.
No. CPSC's product concentration restriction concerns specified toys and care articles. It is not a biomarker threshold or a personal daily dose.[4]
Evidence behind this answer
- Phthalates Business Guidance
agency guidance or assessment · Date not stated
Original official page and selected relevant passages inspected · Covered articles, eight chemicals, concentration restriction and testing exemptions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does one urine result show my usual exposure?
Selected-source overview · Independent review pending. Read the evidence context.
Not reliably in every setting. The week-long sampling study found considerable variability; compound, source and collection timing affect interpretation.[8]
Evidence behind this answer
- Variability over 1 Week in Urinary Phthalate Metabolites among Eight Adults
original repeated sampling study · 2010
Original institutional repository abstract inspected; full PDF not inspected · Original study abstract: methods, results and conclusions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Has FDA's 2026 grouping completed the full new assessment?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA described the grouping evaluation as informing a future cumulative post-market safety assessment, rather than its completed final risk conclusion.[6]
Evidence behind this answer
- FDA Advances Post-Market Review of Phthalates Used in Food Contact Materials
agency guidance or assessment · 2026
Original official page and selected relevant passages inspected · May 2026 CPR grouping and future assessment
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Assessments can group compounds with shared effects
EFSA's 2019 assessment set a temporary group TDI of 50 micrograms per kilogram body weight per day, expressed as DEHP equivalents, for DBP, BBP, DEHP and DINP. DIDP retained a separate value based on a different critical effect. Weighting by relative potency matters: adding raw concentrations is not automatically the same as adding equivalent doses. EFSA also acknowledged limited investigation of other possible outcomes and limitations in occurrence measurements.[5]
FDA's 2026 evaluation is a grouping step
In May 2026 FDA released an evaluation supporting cumulative grouping of DEHP, DCHP, DIOP and DINP among the eight authorized plasticizers. The agency described this as work informing a future post-market assessment and sought input. That is not the same set as EFSA's 2019 group because compounds, mandates and evaluation scope differ. Neither a shared family name nor an authorization count establishes that each substance has an identical reproductive effect or present dietary exposure.[6]
Human associations add evidence without diagnosing cause
A NIH-led pooled analysis used 16 US pregnancy cohorts, including 6,045 pregnancies from 1983–2018. Higher urinary concentrations of several metabolites were associated with greater probability of preterm birth. This supports concern and further prevention research, while remaining observational: correlated exposures, confounding and biomarker timing complicate causal attribution. It cannot determine why one individual delivered early or show that removing one cosmetic product would prevent that outcome.[7]
One urine sample is a limited exposure snapshot
An original study collected all urine voids from eight adults for one week and found substantial within-day and between-day variability for metabolites of DEP and DEHP. Its small sample illustrates measurement issues rather than providing a universal clinical cutoff. Because phthalates are eliminated rapidly, an isolated result reflects sampling time and recent pathways. Repeated research measurements can improve exposure characterization; a commercial panel does not by itself establish an illness or indicate a need for a cleanse.[8]
References
- Phthalates, America's Children and the Environment
Agency guidance or assessment
US EPA · Content/publication date: 2017
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Pages 1–5: uses, routes, metabolism, urine indicator unitsSelected-source access only; check date is distinct from publication date. No independent expert review.
- Phthalates in Food Packaging and Food Contact Applications
Agency guidance or assessment
US FDA · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Authorizations, direct addition, 2022 abandonment and continued evaluationSelected-source access only; check date is distinct from publication date. No independent expert review.
- Phthalates in Cosmetics
Agency guidance or assessment
US FDA · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: DEP use, fragrance constituent labeling and FDA positionSelected-source access only; check date is distinct from publication date. No independent expert review.
- Phthalates Business Guidance
Agency guidance or assessment
US CPSC · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Covered articles, eight chemicals, concentration restriction and testing exemptionsSelected-source access only; check date is distinct from publication date. No independent expert review.
- Updated risk assessment of DBP, BBP, DEHP, DINP and DIDP
Agency scientific opinion
EFSA · Content/publication date: 2019
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Summary: temporary group TDI, relative potency, separate DIDP and uncertaintySelected-source access only; check date is distinct from publication date. No independent expert review.
- FDA Advances Post-Market Review of Phthalates Used in Food Contact Materials
Agency guidance or assessment
US FDA · Content/publication date: 2026
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: May 2026 CPR grouping and future assessmentSelected-source access only; check date is distinct from publication date. No independent expert review.
- Preterm Birth More Likely With Exposure to Phthalates
Original institution research summary
NIEHS · Content/publication date: 2022
Accessed: 2026-10-13 UTC · Original official page and selected relevant passages inspected
Cited sections: Original institution summary of Welch et al. 2022 pooled 16-cohort studySelected-source access only; check date is distinct from publication date. No independent expert review.
- Variability over 1 Week in Urinary Phthalate Metabolites among Eight Adults
Original repeated sampling study
Preau et al./CDC Stacks · Content/publication date: 2010
Accessed: 2026-10-13 UTC · Original institutional repository abstract inspected; full PDF not inspected
Cited sections: Original study abstract: methods, results and conclusionsSelected-source access only; check date is distinct from publication date. No independent expert review.
Scope & review
- Population
- General readers; food exposure, occupational settings and vulnerable populations are distinguished where relevant
- Exposure or intervention
- Phthalates
- Comparison
- Chemical forms, routes, dose and duration; health guidance versus product limits
- Outcomes
- Identity, everyday sources, evidence, practical interpretation and uncertainty
- Timeframe
- Selected sources checked 2026-10-13; historical evidence is dated separately
- Jurisdiction
- US and explicitly identified European or international sources; local rules differ
Bounded selected-source educational explanation. Official assessments, original studies and editorial inference are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-13 UTC: Added definition-first explanation, categories, practical questions and source-linked uncertainty.
What this article still leaves open
- No product-specific safety certificate or individualized exposure diagnosis is provided.
- Jurisdiction-specific implementation, sampling methods and newly published evidence require separate assessment.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.